Organogenesis Holdings
Stock Forecast, Prediction & Price Target
Organogenesis Holdings Financial Estimates
Organogenesis Holdings Revenue Estimates
Organogenesis Holdings EBITDA Estimates
Organogenesis Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $468.05M N/A | $450.89M -3.66% | $433.14M -3.93% | Avg: $457.74M Low: $450.60M High: $464.88M avg. 5.68% | Avg: $488.80M Low: $481.18M High: $496.43M avg. 6.78% | ||
Net Income
% change YoY
| $94.20M N/A | $15.53M -83.51% | $4.94M -68.16% | Avg: $-3.65M Low: $-19.91M High: $11.94M avg. -173.84% | Avg: $11.59M Low: $1.32M High: $26.54M avg. 417.53% | ||
EBITDA
% change YoY
| $89.58M N/A | $40.32M -54.98% | $36.03M -10.64% | Avg: $36.55M Low: $35.98M High: $37.12M avg. 1.46% | Avg: $39.04M Low: $38.43M High: $39.64M avg. 6.78% | ||
EPS
% change YoY
| $0.73 N/A | $0.12 -83.56% | $0.04 -68.58% | Avg: -$0.03 Low: -$0.15 High: $0.09 avg. -179.57% | Avg: $0.09 Low: $0.01 High: $0.2 avg. 388.9% | ||
Operating Expenses
% change YoY
| $280.94M N/A | $323.57M 15.17% | $314.13M -2.91% | Avg: $282.93M Low: $278.52M High: $287.34M avg. -9.93% | Avg: $302.13M Low: $297.42M High: $306.84M avg. 6.78% | ||
FAQ
What is Organogenesis Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 121.84% in 2025-2026.
We have gathered data from 2 analysts. Their low estimate is -19.91M, average is -3.65M and high is 11.94M.
What is Organogenesis Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 6.23% in 2025-2026.
We have gathered data from 2 analysts. Their low revenue estimate is $450.60M, average is $457.74M and high is $464.88M.
What is Organogenesis Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 104.66% in 2025-2026.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.15, average is -$0.03 and high is $0.09.
What is the best performing analyst?
In the last twelve months analysts have been covering Organogenesis Holdings stock. The most successful analyst is Brooks O’Neil.